1. Home
  2. NTLA vs IBCP Comparison

NTLA vs IBCP Comparison

Compare NTLA & IBCP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NTLA
  • IBCP
  • Stock Information
  • Founded
  • NTLA 2014
  • IBCP 1864
  • Country
  • NTLA United States
  • IBCP United States
  • Employees
  • NTLA N/A
  • IBCP N/A
  • Industry
  • NTLA Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • IBCP Major Banks
  • Sector
  • NTLA Health Care
  • IBCP Finance
  • Exchange
  • NTLA Nasdaq
  • IBCP Nasdaq
  • Market Cap
  • NTLA 710.1M
  • IBCP 630.0M
  • IPO Year
  • NTLA 2016
  • IBCP N/A
  • Fundamental
  • Price
  • NTLA $8.12
  • IBCP $31.64
  • Analyst Decision
  • NTLA Buy
  • IBCP Hold
  • Analyst Count
  • NTLA 19
  • IBCP 3
  • Target Price
  • NTLA $38.26
  • IBCP $36.67
  • AVG Volume (30 Days)
  • NTLA 3.2M
  • IBCP 108.7K
  • Earning Date
  • NTLA 05-08-2025
  • IBCP 04-24-2025
  • Dividend Yield
  • NTLA N/A
  • IBCP 3.29%
  • EPS Growth
  • NTLA N/A
  • IBCP 6.78
  • EPS
  • NTLA N/A
  • IBCP 3.14
  • Revenue
  • NTLA $45,569,000.00
  • IBCP $219,516,000.00
  • Revenue This Year
  • NTLA N/A
  • IBCP N/A
  • Revenue Next Year
  • NTLA N/A
  • IBCP $6.51
  • P/E Ratio
  • NTLA N/A
  • IBCP $10.08
  • Revenue Growth
  • NTLA N/A
  • IBCP 6.57
  • 52 Week Low
  • NTLA $5.90
  • IBCP $22.53
  • 52 Week High
  • NTLA $28.18
  • IBCP $40.32
  • Technical
  • Relative Strength Index (RSI)
  • NTLA 50.39
  • IBCP 57.45
  • Support Level
  • NTLA $7.21
  • IBCP $30.76
  • Resistance Level
  • NTLA $9.27
  • IBCP $32.05
  • Average True Range (ATR)
  • NTLA 0.61
  • IBCP 0.87
  • MACD
  • NTLA 0.02
  • IBCP 0.18
  • Stochastic Oscillator
  • NTLA 44.20
  • IBCP 81.28

About NTLA Intellia Therapeutics Inc.

Intellia Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. Intellia is focused on using this technology to treat genetically defined diseases. It's evaluating multiple gene editing approaches using in vivo and ex vivo therapies to address diseases with high unmet medical needs, including ATTR amyloidosis, hereditary angioedema, sickle cell disease, and immuno-oncology. Intellia has formed collaborations with several companies to advance its pipeline, including narrow-moat Regeneron and wide-moat Novartis.

About IBCP Independent Bank Corporation

Independent Bank Corp (Ionia MI) operates as a commercial bank. It offers a broad range of banking services to individuals and businesses, including checking and savings accounts, commercial lending, direct and indirect consumer financing, mortgage lending, and safe deposit box services. It also provides internet and mobile banking capabilities to its customers.

Share on Social Networks: